Life-threatening pulmonary hemorrhage typically defined as >100-600 mL in 24 hours or any volume causing gas exchange compromise.
Also known as: hemoptysis, massive hemoptysis, life-threatening hemoptysis, pulmonary hemorrhage
Overview
Expectoration of blood from the lower respiratory tract. Massive (life-threatening) hemoptysis lacks a single universal threshold; commonly defined as >100-600 mL in 24 hours, >50 mL in a single expectoration, or any volume producing hemodynamic instability or hypoxemia. Patients usually die from asphyxiation rather than exsanguination because the airways tolerate ~150 mL of blood before flooding gas-exchange units.
Epidemiology
Accounts for ~5-15% of hemoptysis presentations. Mortality 50-80% if untreated; <20% with rapid bronchial artery embolization and supportive care.
Try two board-style Massive Hemoptysis questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1PulmonaryMedium
A 58-year-old man with a 40-pack-year smoking history and known bronchiectasis presents after coughing up approximately 300 mL of bright red blood over the past 2 hours. He is given supplemental oxygen and two large-bore IVs, and his coagulation studies are normal. After positioning and airway protection, his vital signs stabilize: blood pressure 124/78 mm Hg, heart rate 92/min, and oxygen saturation 96% on 2 L nasal cannula. A portable chest radiograph shows nonspecific bibasilar opacities and does not localize the bleeding source. Which of the following is the most appropriate next diagnostic test?
AVentilation-perfusion radionuclide scan
BMultidetector CT angiography of the chest
CNoncontrast high-resolution CT of the chest
DSputum acid-fast bacilli smear and culture
ESelective bronchial artery angiography
Reveal answer & full explanation
Correct answer: B — Multidetector CT angiography of the chest
AVentilation-perfusion radionuclide scan
BMultidetector CT angiography of the chest✓
CNoncontrast high-resolution CT of the chest
DSputum acid-fast bacilli smear and culture
ESelective bronchial artery angiography
Why Multidetector CT angiography of the chest is correct
In a hemodynamically stable patient with massive hemoptysis, multidetector CT angiography of the chest is the diagnostic study of choice.
It localizes the bleeding source and reveals the underlying vascular abnormality (bronchial artery hypertrophy, AVM, Rasmussen aneurysm) and parenchymal pathology in a single study.
The chest radiograph has already failed to localize (it identifies the bleeding side in only ~50% of cases), so CT angiography is the logical next step and it maps the vascular anatomy needed to plan bronchial artery embolization.
Why the others are wrong
Ventilation-perfusion radionuclide scan is a test for pulmonary embolism; it neither localizes a bleeding bronchial vessel nor characterizes the airway, and PE is not the likely source in a patient with bronchiectasis and brisk frank hemoptysis.
Selective bronchial artery angiography — this is the invasive step that follows localization and is paired with embolization, not the initial diagnostic study; performed first in a stabilized patient it proceeds without the vascular roadmap CT angiography provides and misses parenchymal and non-bronchial systemic sources.
Sputum acid-fast bacilli smear and culture is appropriate to send for etiology when TB is suspected, but it is an adjunctive microbiologic test that does not localize the bleeding source or guide acute intervention.
Noncontrast high-resolution CT of the chest — HRCT is the standard test for diagnosing bronchiectasis and shows the parenchymal disease, but without contrast it cannot depict the hypertrophied bronchial and nonbronchial systemic arteries, so it provides no vascular roadmap for bronchial artery embolization the way CT angiography does.
Question 2PulmonaryEasy
A 58-year-old woman with a history of recurrent pneumonias presents after coughing up blood at home this morning. She is alert and anxious, with BP 128/76 mm Hg, HR 104/min, RR 22/min, and SpO2 95 percent on room air. She reports no chest pain and no lightheadedness. Which additional history element would best determine whether this episode qualifies as life-threatening hemoptysis?
ATotal volume of blood produced in the past 24 hours
BNumber of weeks over which the bleeding has occurred
CNumber of separate days on which streaking occurred
DPresence of purulent sputum mixed with the blood
EShade of the blood ranging from bright red to dark
Reveal answer & full explanation
Correct answer: A — Total volume of blood produced in the past 24 hours
ATotal volume of blood produced in the past 24 hours✓
BNumber of weeks over which the bleeding has occurred
CNumber of separate days on which streaking occurred
DPresence of purulent sputum mixed with the blood
EShade of the blood ranging from bright red to dark
Why Total volume of blood produced in the past 24 hours is correct
Hemoptysis is triaged by rate and volume because patients with airway bleeding die of asphyxiation from flooded alveoli rather than of exsanguination, and the anatomic dead space of the conducting airways is only about 150 mL.
Definitions vary, with older texts using more than 600 mL in 24 hours and current practice favoring thresholds as low as 100 to 200 mL in 24 hours, or any bleeding that causes gas exchange failure or hemodynamic instability.
Total volume of blood produced in the past 24 hours — quantifying the amount and the rate, ideally by anchoring it to a household measure such as teaspoons, a cup, or a basin, is the element that determines whether this is life-threatening and whether the patient needs urgent bronchoscopy, bronchial artery embolization, and positioning with the bleeding side down.
Why the others are wrong
Number of separate days on which streaking occurred — frequency helps characterize chronicity and the likelihood of an underlying structural lesion but does not establish acuity.
Shade of the blood ranging from bright red to dark — color helps separate hemoptysis from hematemesis and may hint at old versus fresh bleeding, but it does not grade severity.
Number of weeks over which the bleeding has occurred — duration guides the diagnostic differential, and hemoptysis lasting more than a week in a smoker raises malignancy concern, but it does not define life-threatening bleeding.
Presence of purulent sputum mixed with the blood — purulent sputum fits her history of recurrent pneumonias and points toward infection or bronchiectasis as the cause, but it describes the source of the bleeding rather than the amount or rate that defines a life-threatening episode.
Alongside volume, the history should record airway protection ability, anticoagulant use, and any bleeding disorder.
That's 2. Get 7,700+ more.
Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.
You've read your 2 free diagnosis previews. Create your free account to unlock the full Massive Hemoptysis outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Bronchiectasis (any cause, especially cystic fibrosis) — most common in developed world
Tuberculosis with cavitary disease (Rasmussen aneurysm) — most common globally
Lung cancer (bronchogenic carcinoma, especially squamous cell with central cavitation)
Aspergilloma colonizing a pre-existing cavity
Bronchitis (chronic and acute) — most common cause of non-massive hemoptysis
Mitral stenosis, AV malformations, pulmonary embolism with infarction
Vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis, anti-GBM disease)
Coagulopathy and anticoagulant use
Trauma (penetrating or blunt)
Iatrogenic — Swan-Ganz catheter rupture of pulmonary artery, recent bronchoscopy or biopsy
Pathophysiology
Approximately 90% of massive hemoptysis arises from the bronchial circulation (systemic pressure ~100 mmHg) rather than the pulmonary circulation (pressure ~15-25 mmHg). Chronic inflammation, infection, or malignancy stimulates bronchial artery hypertrophy and neovascularization. Erosion of a tortuous, high-pressure bronchial vessel into an airway produces brisk bleeding. Less commonly, pulmonary arterial sources include Rasmussen aneurysm in TB cavities, AV malformations, and iatrogenic PA rupture.
Clinical presentation
Symptoms
Coughing up bright red or clotted blood, often preceded by gurgling or bubbling sensation in chest
Dyspnea and hypoxemia
Hemodynamic instability if volume sufficient
Constitutional symptoms suggestive of underlying etiology (weight loss, fevers, night sweats)
Signs / physical exam
Tachycardia, hypotension if significant volume loss
Localized crackles or wheeze over the bleeding source
CBC, type and crossmatch, coagulation studies (PT/INR, aPTT, fibrinogen)
CMP, troponin if hemodynamic instability
ABG to quantify gas exchange
Sputum studies as appropriate: AFB smear/culture, fungal, bacterial, cytology
ANCA, anti-GBM, ANA, urinalysis if vasculitis suspected
Imaging
Chest radiograph for initial localization (sensitivity poor — may localize bleeding side in only ~50%)
Multidetector CT angiography of the chest as the diagnostic study of choice in stable patients — identifies bleeding source, vascular abnormalities (bronchial artery hypertrophy, AVMs, Rasmussen aneurysm), and underlying pathology
Flexible or rigid bronchoscopy for localization and immediate therapeutic maneuvers when CT unavailable or patient unstable
Bronchial artery angiography for definitive intervention
Diagnostic algorithm
flowchart TD
A[Massive hemoptysis] --> B[Position bleeding side DOWN<br/>O2, IV access x2, T&C]
B --> C{Airway protection?}
C -->|Compromised| D[Intubate w/ large ETT<br/>± mainstem to unaffected side]
C -->|Stable| E[Urgent CT angio chest]
D --> F[Bronchoscopy:<br/>tamponade, APC, topical]
E --> G[Bronchial artery angio +<br/>embolization]
F --> G
G --> H{Bleeding controlled?}
H -->|Yes| I[Treat underlying cause]
H -->|No| J[Surgical resection<br/>or repeat embolization]
Stepwise resuscitation and definitive management of massive hemoptysis.
Treatment
First-line
Position the patient bleeding-side DOWN to protect the contralateral healthy lung from soiling
Supplemental oxygen, large-bore IV access x 2, type and crossmatch, reverse coagulopathy (FFP, PCC, platelets, vitamin K, protamine for heparin, andexanet/idarucizumab for DOACs as appropriate)
Early intubation with a large endotracheal tube (≥8.0 mm) to permit therapeutic bronchoscopy; consider mainstem intubation of unaffected lung or double-lumen tube if expertise available
Suspend antiplatelets and anticoagulants
Empiric IV tranexamic acid (1 g IV over 10 min then infusion or repeat dose) is a reasonable temporizing measure based on emerging evidence
Consult interventional radiology and thoracic surgery EARLY
Bronchial artery embolization (BAE)
First-line definitive therapy for non-trauma, non-iatrogenic massive hemoptysis
Success rate 70-95% with rebleed rate 10-30% at 1 year
Risk of spinal cord ischemia from anterior spinal artery origin off bronchial artery (~1-2%)
Bronchoscopic intervention
Endobronchial balloon tamponade with Fogarty or Arndt blocker
Pulmonary arterial embolization rather than bronchial
Withdraw Swan-Ganz balloon, deflate, leave catheter in place to mark site for intervention
Complications
Asphyxiation (primary cause of death)
Hemorrhagic shock
Aspiration pneumonia and ARDS
Spinal cord ischemia from bronchial artery embolization
Rebleeding (within hours to months)
PANCE pearls
Massive hemoptysis kills by asphyxiation, NOT exsanguination — protect the airway first.
Position bleeding side DOWN if known; if unknown, localize it urgently (CXR, CT angiography, or bronchoscopy), then place the bleeding side down.
Most bleeding (90%) is from BRONCHIAL arteries (systemic pressure) — bronchial artery embolization is first-line definitive therapy.
Swan-Ganz catheter rupture of the pulmonary artery presents as sudden massive hemoptysis in an ICU patient — do NOT remove the catheter; deflate balloon, leave in place to mark the bleeding pulmonary artery for embolization.
Always check anti-GBM and ANCA when diffuse alveolar hemorrhage is suspected — many vasculitic causes present without true frank hemoptysis.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.